Absci (ABSI) Preferred Dividend Payments (2020 - 2021)
Absci (ABSI) posted Preferred Dividend Payments of $242000.0 for Q3 2021, down 76.89% sequentially from $1.0 million in Q2 2021, and down 97.37% YoY from $9.2 million in Q3 2020.
Absci (ABSI) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Absci has reported Preferred Dividend Payments for 2 years, with the latest figure at $242000.0 in Q3 2021.
- Quarterly Preferred Dividend Payments fell 97.37% year-over-year to $242000.0 in Q3 2021, while the trailing twelve-month figure through Jun 2022 was $242000.0 (down 97.99% YoY) and the FY2021 annual result came in at $2.3 million, up 192.82% from the prior year.
- Preferred Dividend Payments fell to $242000.0 in Q3 2021 per ABSI's latest filing, from $1.0 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $9.2 million in Q3 2020 and troughed at $242000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 242,000.00 |
| Jun 30, 2021 | 1.05 Mn |
| Mar 31, 2021 | 995,000.00 |
| Dec 31, 2020 | 780,000.00 |
| Sep 30, 2020 | 9.22 Mn |